Here, we use data from the Penn Aging Brain Cohort (ABC) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) for participants with both 18F-flortaucipir tau PET and high-angular resolution dMRI to test this fully individualized approach. Here, MAPT is linked to Alzheimer disease.